Financial Performance - Net sales reached $10.1 billion, while Operating EBITDA amounted to $703 million [7] - The company received approximately $2.4 billion in cash from the Diamond Infrastructure Solutions partnership, with a potential additional $600 million expected in the second half of 2025 [7] - A final judgment ruling awarded the company approximately $1.2 billion from the NOVA litigation, with cash inflow anticipated in the second half of 2025 [7] Cost Savings and Divestitures - The company announced two divestitures totaling approximately $250 million, at an operating EBITDA multiple of approximately 10x [7] - In-year cost savings are increasing to approximately $400 million, as part of a $1 billion program [7] Capital Allocation - A 50% dividend reduction was announced to prioritize a balanced capital allocation framework [7] - 2025 CapEx is being reduced to approximately $2.5 billion, which is approximately $1 billion lower than original plans [34] Segment Performance - Packaging & Specialty Plastics reported Op EBIT of $632 million, with margins up 1,130 bps YoY [9] - Industrial Intermediates & Infrastructure reported Op EBIT of $192 million, with margins up 680 bps YoY [18] - Performance Materials & Coatings reported Op EBIT of $6 million, with margins up 60 bps YoY [20] Outlook - 3Q25 Net Sales are expected to be ~$10.2B [29]

Financial Performance - Revenue increased by 5.8% to $1,022.0 million in Q2 2025, compared to $965.6 million in Q2 2024[18] - Adjusted EPS increased by 4.1% to $2.04 in Q2 2025, compared to $1.96 in Q2 2024[18] - Available Cash Flow (ACF) increased significantly by 56.5% to $275.4 million YTD Q2 2025, compared to $176.0 million YTD Q2 2024[21, 44] - The company is raising FY-2025 Adjusted EPS outlook to $8.00-$8.15[10, 55] Segment Performance - Allegion Americas revenue increased by 6.6% to $821.5 million in Q2 2025, compared to $770.7 million in Q2 2024[29] - Allegion International revenue increased by 2.9% to $200.5 million in Q2 2025, compared to $194.9 million in Q2 2024[36] - Americas organic revenue growth was 4.5% in Q2 and 4.7% YTD[26] - International organic revenue declined by 2.2% in Q2 and 0.7% YTD[26] Capital Allocation and Acquisitions - The company is accelerating capital deployment[10, 55] - Approximately $44 million was allocated for dividends, equating to $0.51 per ordinary share[12] - The company spent $40 million on share repurchases in Q2 2025[13] - The company announced acquisitions with a combined purchase price of approximately $525 million (€330M purchase price (~$390M) for technology & electronics acquisitions, ~$55M for mechanical portfolio expansion, and ~$80M for complementary software & services)[16] Outlook - The company updated its FY-2025 organic revenue growth outlook to 3.5% to 4.5%[50] - The company expects approximately $40 million of surcharge revenue in the Americas related to tariff mitigation, which is neutral to EPS[49]

Second Quarter 2025 Earnings Conference Call July 24, 2025 Safe Harbor and Non-GAAP Financial Measures Note Regarding Forward-Looking Statements: SUPPLY CHAIN | DEDICATED TRANSPORTATION | FLEET MANAGEMENT SOLUTIONS © 2025 Ryder System, Inc. All Rights Reserved Certain statements and information included in this presentation are "forward-looking statements" under the Federal Private Securities Litigation Reform Act of 1995, including our expectations regarding: our forecast; our outlook; market conditions, s ...

Forward Looking Statements and Non-GAAP Financial Measures Statements and information in this presentation that are not historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are made pursuant to the "safe harbor" provisions of such Act. Forward-looking statements include, but are not limited to, statements regarding our outlook, guidance, expectations, beliefs, hopes, intentions and strategies. These statements are subject to a number of ris ...

Financial Performance - Nasdaq's net revenue for 2Q25 was $1306 million, a 13% increase year-over-year[17] - Solutions revenue reached $991 million, up 10% year-over-year[17] - Non-GAAP operating income was $721 million, a 16% increase year-over-year[17] - Non-GAAP diluted EPS increased by 24% year-over-year to $085[17] - Annualized SaaS revenues grew by 13% year-over-year to $1098 million[17] - Annualized Recurring Revenue (ARR) increased by 10% year-over-year to $2931 million[17] Segment Highlights - Index ETP AUM reached a record level of $745 billion at quarter-end, bolstered by $88 billion in net inflows over the trailing twelve months[13] - Capital Access Platforms revenue grew organically by 9% year-over-year[38] - Financial Technology revenue grew organically by 10% year-over-year[38] - Market Services net revenue increased by 21% year-over-year to $306 million[70]

Confidential © 2024 Novocu © 2025 re GmbH Novocure GmbH 1 © 20254 Novocure GmbH GmbH 4 © 2025 Novocure GmbH 2 2025 key objectives, unlocking TTFields potential | DRIVING COMMERCIAL | ADVANCING | DELIVERING | | --- | --- | --- | | ADOPTION | CLINICAL PIPELINE | PRODUCT INNOVATION | | ✔ NSCLC drive global active | ✔ PANOVA-3 present and | V Launch MyNovocure | | patient growth and | publish data | patient app | | pursue reimbursement | • PANOVA-3 submit to FDA, | • New array utilized by | | ✔ NSCLC CE Mark | ...

Lazard's Business Overview - Lazard is an independent financial advisory and asset management firm[11] - Asset Management AUM reached $248 billion in 2Q25, with 63% in non-USD securities[19] - Financial Advisory had >200 clients in FY24 with fees >$1M[19] Financial Performance & Strategy - Lazard aims to double revenue by 2030 and achieve a 10-15% average annual total shareholder return (TSR)[31] - In 2024, Financial Advisory net revenue was $1731 million and Asset Management net revenue was $1100 million[161] - Lazard targets an $85 million annual revenue per MD in Financial Advisory by 2025, increasing to $10 million by 2028[34] Financial Metrics - Adjusted net revenue for 2024 was $2890 million[159] - The adjusted compensation ratio for 2024 was 659%[154] - The adjusted non-compensation ratio for 2024 was 199%[156]

ICON plc Q2 2025 Results Period Ended June 30, 2025 Forward Looking Statement Statements included in this presentation which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Forward-looking statements include statements regarding our financial guidance and outlook, and may be identified by the use of future tense or other forward-looking words su ...

Second-Quarter 2025 Second Quarter Overall Net Sales $766.5M | 9.2% Diluted Earnings Per Share: $1.82 Adjusted Diluted Earnings Per Share: $1.84 "I am pleased to report that we exceeded our expectations for the second quarter driven by solid growth in HVP components. This was the result of strong GLP-1 elastomer growth, ongoing momentum in HVP conversion mainly related to Annex 1 projects and the continued normalization of customer ordering patterns. The improved performance was concentrated in higher margi ...

2025 Second Quarter Results July 24, 2025 Proprietary © Gentherm Forward-Looking Statements Except for historical information contained herein, statements in this presentation are forward-looking statements that are made by Gentherm Incorporated (the "Company") pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that address future operating, financial or business performance or strategies or expectations are forward-looking statements. The forward- ...